Information Journal Paper
APA:
Copy. (2018). A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia. PLOS NEGLECTED TROPICAL DISEASES, 12(7), 0-0. SID. https://sid.ir/paper/761228/en
Vancouver:
Copy. A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia. PLOS NEGLECTED TROPICAL DISEASES[Internet]. 2018;12(7):0-0. Available from: https://sid.ir/paper/761228/en
IEEE:
Copy, “A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia,” PLOS NEGLECTED TROPICAL DISEASES, vol. 12, no. 7, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/761228/en